Biomarin Pharmaceutical (BMRN) P/E (2009 - 2026)
Biomarin Pharmaceutical (BMRN) P/E from Jun 30, 2009 to Jul 21, 2026. The TTM Biomarin Pharmaceutical (BMRN) P/E is 42.40. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Biomarin Pharmaceutical (BMRN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 42.40 | +29.76% |
| 2025 | 32.67 | +11.44% |
| 2024 | 29.32 | -76.22% |
| 2023 | 123.31 | -46.16% |
| 2022 | 229.03 | -190.19% |
| 2021 | -253.93 | -1463.03% |
| 2020 | 18.63 | -106.36% |
| 2019 | -293.06 | +143.57% |
| 2018 | -120.32 | +21.58% |
| 2017 | -98.97 | +243.01% |
| 2016 | -28.85 | -70.54% |
| 2015 | -97.95 | -1.73% |
| 2014 | -99.68 | +76.45% |
| 2013 | -56.49 | +6.96% |
| 2012 | -52.81 | -46.27% |
| 2011 | -98.30 | -836.43% |
| 2010 | 13.35 | -94.30% |
| 2009 | 234.18 | N/A |
Comparison Biomarin Pharmaceutical (BMRN) P/E with competitors
Biomarin Pharmaceutical (BMRN) P/E is 42.40.